1Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials[J]. Arch Intern Med, 1994,154∶1449-1457.
2Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation An individual patient meta-analysis[J]. JAMA, 2002, 288∶2441-2448.
4Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation[J]. Ann Thorac Surg, 1996, 61∶755-759.
5Sto¨ llberger C , Schneider B , and Finsterer J . Elimination of the left atrial appendage to prevent stroke or embolism? anatomic, physiologic, and pathophysiologic considerations[J]. Chest, 2003, 124∶2356-2362.
6Katz ES, Tsiamtsiouris T, Applebaum RM, et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic study[J]. J Am Coll Cardiol, 2000, 36∶468-471.
7Crystal E, Lamy A, Connolly SJ, et al. Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention[J]. Am Heart J, 2003 ,145(1)∶174-178.
8Sievert H, Lesh M D, Trepels T, et al. Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation Early Clinical Experience[J]. Circulation, 2002,105∶1887-1889.
9Hanna IR, Kolm P, Martin R, et al. Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO) Six-month echocardiographic follow-Up[J]. J Am Coll Cardiol, 2004,43∶1868 -1872.
10Meier B, Palacios I, Windecker S, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation[J]. Catheter Cardiovasc Interv, 2003, 60∶417-422.
7Wolf PA,Abbott RD,Kannel WB,et al.Atrial fibrillation as an independent risk factor for stroke:the Framingham study[J].Stroke,1991,22(8):983-988.
8Copland M,Walker ID,Tait RC.Oral anticoagulation and hemorrhagic complication in an elderly population with atrial fibrillation[J].Arch Inten Med,2001,161:2125-2128.
9Fuster V,Rydén LE,Asinger RW,et al.ACC/AHA Practice Guidelines[J].Circulation,2001,104:2118.
10Yamaguchi T Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation.A multicenter,prospective,randomized trial.Japanese Nonvalver fibrillation Embolish secondary prevention cooperative study group[J].Stroke,2000,31:817-821.
